What is the average price target for EVOLUS INC (EOLS) stock?
13 analysts have analysed EOLS and the average price target is 14.96 USD. This implies a price increase of 271.22% is expected in the next year compared to the current price of 4.03.
NASDAQ:EOLS • US30052C1071
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EVOLUS INC (EOLS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | BTIG | Reiterate | Buy -> Buy |
| 2026-02-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-22 | BTIG | Maintains | Buy -> Buy |
| 2026-01-13 | Stifel | Maintains | Buy -> Buy |
| 2026-01-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-12-24 | Needham | Reiterate | Hold -> Hold |
| 2025-12-02 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-08 | BTIG | Reiterate | Buy -> Buy |
| 2025-08-06 | BTIG | Maintains | Buy -> Buy |
| 2025-08-06 | Needham | Downgrade | Buy -> Hold |
| 2025-08-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-08 | Needham | Reiterate | Buy -> Buy |
| 2025-04-17 | BTIG | Initiate | Buy |
| 2025-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-05 | Needham | Reiterate | Buy -> Buy |
| 2025-03-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-27 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-21 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 202.085M 35.99% | 266.274M 31.76% | 297.176M 11.61% | 336.62M 13.27% | 395.93M 17.62% | 468.39M 18.30% | 580.22M 23.88% | 653.13M 12.57% | 842.36M 28.97% | 1.132B 34.38% | |
| EBITDA YoY % growth | -30.974M 44.47% | -21.938M 29.17% | -30.094M -37.18% | 21.689M 172.07% | 59.046M 172.24% | 169.65M 187.32% | 286.08M 68.63% | 357.45M 24.95% | 414.95M 16.09% | 471.38M 13.60% | |
| EBIT YoY % growth | -36.107M 39.32% | -27.235M 24.57% | -37.6M -38.06% | 7.636M 120.31% | 33.549M 339.35% | 68.288M 103.55% | 80.019M 17.18% | 110.19M 37.70% | 108.27M -1.74% | N/A | |
| Operating Margin | -17.87% | -10.23% | -12.65% | 2.27% | 8.47% | 14.58% | 13.79% | 16.87% | 12.85% | N/A | |
| EPS YoY % growth | -0.62 32.61% | -0.25 59.68% | -0.43 -72.00% | -0.04 91.30% | 0.29 885.38% | 1.93 558.33% | 1.86 -4.01% | 2.32 24.91% | 4.80 107.19% | 5.46 13.59% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 11.60% | -0.05 79.30% | -0.06 47.45% | 0.10 64.34% | -0.06 53.85% | 0.04 185.71% | 0.01 117.65% | 0.16 65.51% |
| Revenue Q2Q % growth | 73.734M 7.61% | 83.769M 20.73% | 80.807M 17.17% | 98.296M 10.18% | 83.742M 13.57% | 97.41M 16.28% | 93.636M 15.88% | 118.83M 20.89% |
| EBITDA Q2Q % growth | -3.856M 66.35% | 5.338M 149.32% | 5.81M 218.28% | 14.779M 104.84% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.59M 57.07% | 1.411M 109.99% | 1.271M 112.50% | 9.475M 3,356.01% | 408K 107.30% | 7.242M 413.25% | 5.1M 301.26% | 15.912M 67.94% |
All data in USD
13 analysts have analysed EOLS and the average price target is 14.96 USD. This implies a price increase of 271.22% is expected in the next year compared to the current price of 4.03.
EVOLUS INC (EOLS) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of EVOLUS INC (EOLS) is -0.13 USD and the consensus revenue estimate is 73.73M USD.
The expected long term growth rate for EVOLUS INC (EOLS) is 15.71%.